Respiratory Syncytial Virus Immunization Coverage Among Infants Through Receipt of Nirsevimab Monoclonal Antibody or Maternal Vaccination -- United States, October 2023-March 2024.

Saved in:
Bibliographic Details
Title: Respiratory Syncytial Virus Immunization Coverage Among Infants Through Receipt of Nirsevimab Monoclonal Antibody or Maternal Vaccination -- United States, October 2023-March 2024.
Authors: Boundy, Ellen O.1,2, Fast, Hannah1, Jatlaoui, Tara C.1,2, Razzaghi, Hilda1,2, Harris, LaTreace1, Nguyen, Kimberly1,2, Mells, Jamie1,2, Peacock, Georgina1, Black, Carla L.1
Source: MMWR: Morbidity & Mortality Weekly Report. 8/21/2025, Vol. 74 Issue 31, p484-489. 6p.
Database: Academic Search Ultimate
Description
ISSN:01492195
DOI:10.15585/mmwr.mm7431a3